Dianthus Therapeutics, Inc.NASDAQ: DNTH

Dianthus Therapeutics to Participate in Three Investor Conferences During September

· Issued by Dianthus Therapeutics, Inc. via GlobeNewswire

Summary by 6ix AI

Dianthus Therapeutics, Inc., a clinical-stage biotechnology company developing therapies for severe autoimmune diseases, will take part in three investor conferences between September 8, 2026 and September 10, 2026.

Key details

  • Wells Fargo 21st Annual Healthcare Conference: CEO Marino Garcia and Ryan Savitz, Executive Vice President, Chief Financial Officer and Chief Business Officer, will host one-on-one investor meetings on September 8, 2026.
  • Citi's 2026 Biopharma Back to School Conference: Marino Garcia will take part in a fireside chat on Wednesday, September 9, 2026, at 4:20 p.m. ET and host one-on-one investor meetings.
  • 2026 Cantor Global Healthcare Conference: Marino Garcia will take part in a fireside chat on Thursday, September 10, 2026, at 8:35 a.m. ET and host one-on-one investor meetings.
  • Webcasts of the presentations at the Citi and Cantor conferences may be accessed under News and Events in the Investors section of the Dianthus Therapeutics website.

6ix AI wrote this summary from the release below and checked it against the release.

NEW YORK and WALTHAM, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today announced the Company's participation in three investor conferences.

  • Wells Fargo 21st Annual Healthcare Conference: Marino Garcia, CEO, and Ryan Savitz, EVP, CFO & CBO of Dianthus Therapeutics, will host one-on-one investor meetings on September 8, 2026.

  • Citi's 2026 Biopharma Back to School Conference: Marino Garcia will participate in a fireside chat on Wednesday, September 9, 2026, at 4:20 p.m. ET and host one-on-one investor meetings.

  • 2026 Cantor Global Healthcare Conference: Marino Garcia will participate in a fireside chat on Thursday, September 10, 2026, at 8:35 a.m. ET and host one-on-one investor meetings.

Webcasts of the presentations at the Citi and Cantor conferences may be accessed under "News and Events" in the Investors section of the Dianthus Therapeutics website.

About Dianthus Therapeutics
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases. Based in New York City and Waltham, Mass., Dianthus is comprised of an experienced team of biotech and pharma executives who aim to deliver transformative medicines for people living with severe autoimmune and inflammatory diseases.

To learn more, please visit www.dianthustx.com and follow us on LinkedIn.

Contact
Jennifer Davis Ruff
Dianthus Therapeutics
[email protected]

Dianthus Therapeutics, Inc. on 6ix

Story so far

Earlier from Dianthus Therapeutics

Later from Dianthus Therapeutics

All Dianthus Therapeutics news releases